Business Services Industry

Drugmaker ready for outbreak.(Spotlight: RIMS 2007 Trends & Developments)(F. Hoffmann-La Roche Ltd. preparations for a deadly pandemic)(Brief article)

Business Insurance, May, 2007

Byline: Gloria Gonzalez Being the manufacturer of the No. 1 prescribed influenza medication has put pharmaceutical company F. Hoffmann-La Roche Ltd. at the forefront of preparations for a potentially deadly pandemic. As part of its pandemic preparations, the Basel, Switzerland-based company has developed and tested a global manufacturing network that can produce in excess of 400 million doses of its influenza drug Tamiflu.

Roche has received and filled orders for Tamiflu from more than 80 countries, some of which are stockpiling or intend to stockpile enough of the drug to treat 20% to 40% of their population in the event of a pandemic. A key question for corporations planning for a potential pandemic is whether they should stockpile the drug for their...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement